Background: Early, accurate diagnosis of RA is critical to improving outcomes. Patients with RA may develop a variety of symptoms including joint pain, swelling and stiffness. The Symptoms in Persons at Risk of Rheumatoid Arthritis (SPARRA) questionnaire was derived to assess the presence, severity and impact of common symptoms in patients at risk of RA (1). However, to date there is little data available on how common these symptoms are in primary care consulters. Objectives: To describe the prevalence of self-reported inflammatory joint symptoms in primary care patients consulting for both musculoskeletal and non-musculoskeletal complaints. Methods: Questionnaires were sent to 10161 individuals, of whom 5050 had consulted primary care for musculoskeletal problems. The remainder were matched to this sample by age, gender and general practice and had consulted for any non-musculoskeletal indication. Respondents provided data on presence of common symptoms such as joint pain, stiffness and swelling. The prevalence of these symptoms, their severity and impact was compared between musculoskeletal and non-musculoskeletal consulters. Results: 4549 people responded to the survey (adjusted response 45.8%) of whom 52.3% were in the musculoskeletal consultation group. The mean (SD) age was 61.6 (14.8) years and 58.9% were female. Symptoms commonly associated with inflammatory arthritis were common in both groups. 89.1% of musculoskeletal consulters reported current joint pain, compared with 74.9% in the non-MSK consulter group, 48.7% of MSK consulters reported joint swelling compared to 37.3% of non-MSK consulters and 77.9% of MSK consulters reported joint stiffness (64.3% in non-MSK group). A similar proportion in each group reported fatigue (59.5% vs 55%). Joint symptoms remained common symptoms in both groups even when severity and impact of symptoms was considered. Conclusions: Although symptoms such as joint pain, swelling, and stiffness are predictive of inflammatory arthritis, a large proportion of those consulting primary care for non-musculoskeletal reasons routinely report these symptoms when prompted. This compounds the challenges of diagnosing inflammatory arthritis in a non-specialist setting where new approaches are needed to ensure accurate, early diagnosis, facilitating a treat to target approach. Several clinical manifestations and laboratory findings have been found to be associated to increased risk of mortality in univariable analyses (1). Objectives: Here we present a mortality predicting model in a long-term observational unselected nationwide cohort aiming to enhance the knowledge of long-term prognosis in MCTD. Methods: 135 patients were included from our nationwide MCTD cohort. Abnormal high resolution computed tomography (CT) findings of ground glass attenuation and reticular patterns were defined as Interstitial Lung Disease (ILD) and expressed as percentage of Total Lung Volume (TLV). Pulmonary function tests and laboratory tests were performed within 2 months of the HRCT examination. Pleuritis was defined as typical pleurisity for more than one day, pleural effusions or pleural rub present at or before baseline. Pericarditis was defined as typical pericardial pain for more than one day, pericardial effusion, pericardial rub or pericarditis by electrocardiography at or before baseline. Myositis was confirmed by muscle biopsy and/or electromyogram and CK elevation at or before baseline. Cox regression analyses were used to find the predictive factors of mortality. Variables at a significant level of P<.25 where considered a candidate in the prediction model by manual backward elimination procedure. Results: 21 patients died after a mean (standard deviation) observation of 9 (2) years. The predictive model is shown in Table 1 . According to the Harrell's C index, patient outcomes were accurately predicted by this model 85% of the time. *Patients were divided in 6 age groups at diagnosis (<25 years, 26 to 35 years, 36 to 45 years, 46 to 55 years, 56-65 years and above 65 years). FVC = Forced Vital Capacity % of predicted, DLCO = diffusing capacity of the lung for carbon monoxide % of predicted, ESR = erythrocyte sedimentation rate, TLV = total lung volume, Hb = Haemoglobin.
Conclusions:
The strongest predicting factors of mortality in MCTD is increasing % ILD of TLV, pericarditis, male gender, DLCO less than 60% of predicted and increasing age at diagnosis. Background: The excess mortality associated with rheumatoid arthritis (RA) is due largely to cardiovascular disease. This highest risk is not related primarily to traditional cardiovasculr/atherosclerosis risk factors. The presence of RA indepedently, as well as high inflammation associated with RA has been reported as a cardiovascular risk factors. Also, subclinical decreased kidney function has been identified as an independent risk factor for CV events in patients with RA. The potential impact of impaired kidney function on atherosclerosis in RA requires more elucidation. Objectives: To assess the role of renal parameters, alongside with inflammation and traditional cardiovascular risk factors in predicting cardiovascular disease; as manifested by carotid intima media thickness (cIMT), among RA population. Methods: cIMT measurement was carried out in 68 RA patients, and correlated with renal function parameters with adjustment for traditional CV risk factors and RA associated inflammation. Glomerular filtration rate (GFR) was estimated with the abbreviated Modification of Diet in Renal Disease formula. Linear regression determined the association between renal parameters and the thickness of cIMT.
